Preprint · CC-BY
via OpenAlex
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease
Miranda E. Orr, Valentina R. Garbarino, Juan Pablo Palavicini, Justin Melendez, Nicolas R. Barthélemy, Yingxin He, Tiffany F. Kautz, Marisa Lopez‐Cruzan, Julia Mathews, Peng Xu, Bin Zhang, Afaf Saliba, Nagarjunachary Ragi, Kumar Sharma, Suzanne Craft
Research Square · 2024 · ▲ 8 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-3994894/v1
- Canonical
- link ↗
- Fetched
- 2026-06-15 MST
Cite this
APA
Orr, M.E., Garbarino, V.R., Palavicini, J.P., Melendez, J., Barthélemy, N.R., He, Y., Kautz, T.F., Lopez‐Cruzan, M., Mathews, J., Xu, P., Zhang, B., Saliba, A., Ragi, N., Sharma, K., Craft, S., Petersen, R.C., Espíndola‐Netto, J.M., Xue, A., Tchkonia, T., & Kirkland, J.L. (2024). Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-3994894/v1
Vancouver
Orr ME, Garbarino VR, Palavicini JP, Melendez J, Barthélemy NR, He Y, et al. Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease. Research Square. 2024. doi:10.21203/rs.3.rs-3994894/v1.
BibTeX
@unpublished{miranda2024Evalua,
title = {Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease},
author = {Miranda E. Orr and Valentina R. Garbarino and Juan Pablo Palavicini and Justin Melendez and Nicolas R. Barthélemy and Yingxin He and Tiffany F. Kautz and Marisa Lopez‐Cruzan and Julia Mathews and Peng Xu and Bin Zhang and Afaf Saliba and Nagarjunachary Ragi and Kumar Sharma and Suzanne Craft and Ronald C. Petersen and Jair Machado Espíndola‐Netto and Ailing Xue and Tamar Tchkonia and James L. Kirkland and Sudha Seshadri and Arash Salardini and Nicolas Musi and Randall J. Bateman and Mitzi M. Gonzales},
journal = {Research Square},
year = {2024},
doi = {10.21203/rs.3.rs-3994894/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Medicine 2023
Preprint · OA
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
Neurotherapeutics 2025
Open access · CC-BY
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease
Nature Medicine 2024
Preprint · OA
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
European Journal of Clinical Nutrition 2021
Open access · OA
Mediterranean diet and the hallmarks of ageing
Nature Reviews Genetics 2023
Open access · OA
Autophagy genes in biology and disease
Nature Reviews Neurology 2019
Citation only